Fusileo M Cream is a topical medication combining Mometasone furoate (0.1% w/w), a potent corticosteroid, with Fusidic Acid (2% w/w), a bacteriostatic antibiotic, designed to treat inflammatory skin conditions complicated by bacterial infections. Mometasone acts by reducing inflammation, redness, and itching through its anti-inflammatory, antipruritic, and vasoconstrictive properties, providing symptomatic relief in conditions such as eczema, psoriasis, and dermatitis. Fusidic Acid targets susceptible Gram-positive bacteria, particularly Staphylococcus aureus, by inhibiting bacterial protein synthesis, thereby preventing the spread of infection and promoting healing. The combination is particularly effective in managing infected dermatoses where inflammation and bacterial colonization coexist. Fusileo M Cream should be applied topically to the affected area once or twice daily as prescribed, avoiding contact with eyes and mucous membranes. It is intended for short-term use to minimize potential side effects associated with corticosteroids, such as skin thinning or systemic absorption. Patients should follow medical advice strictly and report any adverse reactions like irritation or allergic responses. Fusileo M Cream offers a dual-action approach, addressing both inflammation and infection to accelerate recovery and improve skin health.